Intracranial Hemorrhage

Incidence of Delayed Traumatic Intracranial Hemorrhage Low in Older Adults With Blunt Head Trauma

Incidence of Delayed Traumatic Intracranial Hemorrhage Low in Older Adults With Blunt Head Trauma

By

Only patients transported via EMS were enrolled, suggesting that these findings are limited to those with more severe blunt head injury vs those who self-present to the emergency department.

Intensive BP Lowering Does Not Benefit ICH With Spot Sign

Intensive BP Lowering Does Not Benefit ICH With Spot Sign

By

Although spot sign predicted ICH expansion, it proved to be a less robust diagnostic marker than demonstrated by previous single-center cohort studies.

Higher Risk for Symptomatic Intracranial Hemorrhage After Endovascular Treatment for Stroke

Higher Risk for Symptomatic Intracranial Hemorrhage After Endovascular Treatment for Stroke

By

Risk for symptomatic intracranial hemorrhage after endovascular treatment for acute ischemic stroke is significantly higher in real-world practice than rates reported by clinical trials.

Intracranial Hemorrhage Associated with Arteriovenous Malformations Linked to Better Outcomes

Intracranial Hemorrhage Associated with Arteriovenous Malformations Linked to Better Outcomes

By

Compared with other sources of ICH, those associated with arteriovenous malformations had lower odds of death.

Migraine-Associated Stroke Not Linked to Atherosclerosis

Migraine-Associated Stroke Not Linked to Atherosclerosis

By

Intracranial atherosclerosis was lower in patients with migraine compared with those without migraine.

Antiplatelet Pretreatment Linked to Intracranial Hemorrhage Mortality

Antiplatelet Pretreatment Linked to Intracranial Hemorrhage Mortality

By

Patients receiving treatment with vitamin K antagonists (VKA) or antiplatelet agents face a significantly increased risk of mortality within 24 hours of intracranial hemorrhage.

SSRI Use Tied to Risk of Intracranial Hemorrhage

SSRI Use Tied to Risk of Intracranial Hemorrhage

By

Concomitant use of oral anticoagulants contributed to a significantly higher increased risk for ICH.

Should Stroke Patients of Asian Descent Get Less tPA?

Should Stroke Patients of Asian Descent Get Less tPA?

By

The idea of low-dose tPA will likely not be abandoned despite recent findings.

Intracranial Bleeding Risk With Warfarin Greater Than Expected

Intracranial Bleeding Risk With Warfarin Greater Than Expected

Risk factors differ from ischemic stroke.

Idarucizumab Promising in Dabigatran-Treated Patients With ICH

Idarucizumab Promising in Dabigatran-Treated Patients With ICH

By

REVERSE-AD is an ongoing phase 3 cohort study evaluating the reversal effects of idarucizumab on dabigatran.

MRI May Help Determine IV tPA Eligibility in Stroke of Unknown Onset

MRI May Help Determine IV tPA Eligibility in Stroke of Unknown Onset

By

Treatment with IV tPA appeared safe and feasible with stroke onset confirmation from MRI.

Long-Term Seizure Risk Higher in Patients With Stroke vs Traumatic Brain Injury

Long-Term Seizure Risk Higher in Patients With Stroke vs Traumatic Brain Injury

By

Surprisingly, multiple types of stroke were associated with a greater risk of seizure than TBI.

Intracerebral Hemorrhage May Mimic Transient Ischemic Attack

Intracerebral Hemorrhage May Mimic Transient Ischemic Attack

By

Patients with symptoms of TIA should undergo brain imaging to rule out ICH prior to antithrombotic therapy.

NOAC-Associated Intracerebral Hemorrhage Linked to Adverse Outcomes

NOAC-Associated Intracerebral Hemorrhage Linked to Adverse Outcomes

By

The study did not establish whether early intervention improves outcomes.

Endovascular Intervention Linked to Better Functional Outcome After Stroke

Endovascular Intervention Linked to Better Functional Outcome After Stroke

By

Compared to standard treatment with IV tPA, endovascular thrombectomy resulted in better functional outcomes at 90 days.

Treatment of Hemorrhage After Thrombolysis Does Not Reduce Mortality Risk

Treatment of Hemorrhage After Thrombolysis Does Not Reduce Mortality Risk

By

Treatment of intracerebral hemorrhage after thrombolysis did not result in reduced mortality or expansion of the hematoma.

Neutrophil Count Predicts Hemorrhage, Post-Stroke Outcomes

Neutrophil Count Predicts Hemorrhage, Post-Stroke Outcomes

By

A simple blood test may indicate risk of intracerebral hemorrhage and post-stroke outcomes.

Oral Anticoagulant Use on the Rise in Atrial Fibrillation

Oral Anticoagulant Use on the Rise in Atrial Fibrillation

NOACs are prescribed to patients with lower stroke risk compared to those prescribed Warfarin.

Stent Use in Intracranial Arterial Stenosis Raises Stroke Risk

Stent Use in Intracranial Arterial Stenosis Raises Stroke Risk

Those treated with a stent were twice as likely to suffer a stroke or transient ischemic attack compared to those treated with medication alone.

Risk of Intracranial Bleeds Higher with Warfarin than Dabigatran

Risk of Intracranial Bleeds Higher with Warfarin than Dabigatran

Those taking dabigatran (Pradaxa) had higher risk of major bleeds, including gastrointestinal bleeding.

Sign Up for Free e-newsletters

CME Focus